Profile
Sanjeev Ahuja worked as Chief Medical Officer at Celtaxsys, Inc. and Mayne Pharma Group Ltd.
He also worked as Chief Medical Officer at Fresh Tracks Therapeutics, Inc. from 2019 to 2020.
Ahuja holds an MBA from the University of Cincinnati and a doctorate from Armed Forces Medical College.
Former positions of Sanjeev Ahuja
Companies | Position | End |
---|---|---|
FRESH TRACKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-02-28 |
MAYNE PHARMA GROUP LIMITED | Chief Tech/Sci/R&D Officer | - |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | - |
Training of Sanjeev Ahuja
University of Cincinnati (Ohio) | Masters Business Admin |
Armed Forces Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
MAYNE PHARMA GROUP LIMITED | Health Technology |
Private companies | 1 |
---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Sanjeev Ahuja